Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 11, 2010, Pages 1112-1117

  Mochel, Fanny ^a   Boildieu, Nadège ^b   Barritault, Julie ^b   Sarret, Catherine ^c,d   Eymard Pierre, Eleonore ^c,d   Seguin, François ^b   Schiffmann, Raphael ^e   Boespflug Tanguy, Odile ^c,f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^f HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Biomarker; Leukodystrophy; N acetylaspartylglutamate; NMR spectroscopy; Pelizaeus Merzbacher disease

Indexed keywords

N ACETYLASPARTYLGLUTAMIC ACID;

ADULT; ARTICLE; CANAVAN DISEASE; CEREBROSPINAL FLUID LEVEL; CHILD; DIAGNOSTIC VALUE; GENE DUPLICATION; HUMAN; LEUKODYSTROPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELIZAEUS MERZBACHER DISEASE; POINT MUTATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

NON-A, NON-B HEPATITIS VIRUS;

EID: 77956652849     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.07.005     Document Type: Article

References (22)

1. Arun P., Madhavarao C.N., Moffett J.R., Namboodiri M.A. Regulation of N-acetylaspartate and N-acetylaspartylglutamate biosynthesis by protein kinase activators. J. Neurochem. 2006, 98:2034-2042.
2. Burlina A.P., Ferrari V., Burlina A.B., Ermani M., Boespflug-Tanguy O., Bertini E. N-acetylaspartylglutamate (NAAG) in Pelizaeus-Merzbacher disease. Adv. Exp. Med. Biol. 2006, 576:353-359. discussion 361-353.
3. Burlina A.P., Ferrari V., Divry P., Gradowska W., Jakobs C., Bennett M.J., Sewell A.C., Dionisi-Vici C., Burlina A.B. N-acetylaspartylglutamate in Canavan disease: an adverse effector?. Eur. J. Pediatr. 1999, 158:406-409.
4. Sartori S., Burlina A.B., Salviati L., Trevisson E., Toldo I., Laverda A.M., Burlina A.P. Increased level of N-acetylaspartylglutamate (NAAG) in the CSF of a patient with Pelizaeus-Merzbacher-like disease due to mutation in the GJA12 gene. Eur. J. Paediatr. Neurol. 2008, 12:348-350.
5. Wolf N.I., Willemsen M.A., Engelke U.F., van der Knaap M.S., Pouwels P.J., Harting I., Zschocke J., Sistermans E.A., Rating D., Wevers R.A. Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. Neurology 2004, 62:1503-1508.
6. Mochel F., Engelke U.F., Barritault J., Yang B., McNeill N.H., Thompson J.N., Vanderver A., Wolf N.I., Willemsen M.A., Verheijen F.W., Seguin F., Wevers R.A., Schiffmann R. Elevated CSF N-acetylaspartylglutamate in patients with free sialic acid storage diseases. Neurology 2010, 74:302-305.
7. Schiffmann R., van der Knaap M.S. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 2009, 72:750-759.
8. Saugier-Veber P., Munnich A., Bonneau D., Rozet J.M., Le Merrer M., Gil R., Boespflug-Tanguy O. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat. Genet. 1994, 6:257-262.
9. Cailloux F., Gauthier-Barichard F., Mimault C., Isabelle V., Courtois V., Giraud G., Dastugue B., Boespflug-Tanguy O. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease, Eur J Hum Genet 2000, 8:837-845.
10. Mochel F., Barritault J., Boldieu N., Eugene M., Sedel F., Durr A., Seguin F. Contribution of in vitro NMR spectroscopy to metabolic and neurodegenerative disorders. Rev Neurol (Paris) 2007, 163:960-965.
11. Wishart D.S., Knox C., Guo A.C., Eisner R., Young N., Gautam B., Hau D.D., Psychogios N., Dong E., Bouatra S., Mandal R., Sinelnikov I., Xia J., Jia L., Cruz J.A., Lim E., Sobsey C.A., Shrivastava S., Huang P., Liu P., Fang L., Peng J., Fradette R., Cheng D., Tzur D., Clements M., Lewis A., De Souza A., Zuniga A., Dawe M., Xiong Y., Clive D., Greiner R., Nazyrova A., Shaykhutdinov R., Li L., Vogel H.J., Forsythe I. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009, 37:D603-610.
12. Mochel F., Sedel F., Vanderver A., Engelke U.F., Barritault J., Yang B.Z., Kulkarni B., Adams D.R., Clot F., Ding J.H., Kaneski C.R., Verheijen F.W., Smits B.W., Seguin F., Brice A., Vanier M.T., Huizing M., Schiffmann R., Durr A., Wevers R.A. Cerebellar ataxia with elevated cerebrospinal free sialic acid. Brain 2009, 132:801-809.
13. van der Post J.P., de Visser S.J., de Kam M.L., Woelfler M., Hilt D.C., Vornov J., Burak E.S., Bortey E., Slusher B.S., Limsakun T., Cohen A.F., van Gerven J.M. The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693. Br. J. Clin. Pharmacol. 2005, 60:128-136.
14. Baslow M.H. Functions of N-acetyl-l-aspartate and N-acetyl-l-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J. Neurochem. 2000, 75:453-459.
15. Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 2001, 78:736-745.
16. Regis S., Grossi S., Corsolini F., Biancheri R., Filocamo M. PLP1 gene duplication causes overexpression and alteration of the PLP/DM20 splicing balance in fibroblasts from Pelizaeus-Merzbacher disease patients. Biochim. Biophys. Acta 2009, 1792:548-554.
17. Dhaunchak A.S., Nave K.A. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proc. Natl Acad. Sci. USA 2007, 104:17813-17818.
18. Boucher S.E., Cypher M.A., Carlock L.R., Skoff R.P. Proteolipid protein gene modulates viability and phenotype of neurons. J. Neurosci. 2002, 22:1772-1783.
19. Kitagawa K., Sinoway M.P., Yang C., Gould R.M., Colman D.R. A proteolipid protein gene family: expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide. Neuron 1993, 11:433-448.
20. Kamasawa N., Sik A., Morita M., Yasumura T., Davidson K.G., Nagy J.I., Rash J.E. Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning. Neuroscience 2005, 136:65-86.
21. Miyaji T., Echigo N., Hiasa M., Senoh S., Omote H., Moriyama Y. Identification of a vesicular aspartate transporter. Proc. Natl Acad. Sci. USA 2008, 105:11720-11724.
22. Aula N., Kopra O., Jalanko A., Peltonen L. Sialin expression in the CNS implicates extralysosomal function in neurons. Neurobiol. Dis. 2004, 15:251-261.